Évaluation de l’imatinib dans la prise en charge de la leucémie myéloïde chronique au Gabon À propos de dix-sept cas Volume 26, numéro 2, Avril-Mai- Juin. REVUE MEDICALE DE LIEGE. Cliquer ICI pour déclencher le téléchargement de l’article. COMMENT JE TRAITE LA LEUCEMIE MYELOIDE CHRONIQUE. Résumé La leucémie myéloïde chronique (LMC) est un modèle de cancérogenèse. Son pronostic a été exceptionnellement amélioré grâce.

Author: Sajinn Jushura
Country: Rwanda
Language: English (Spanish)
Genre: Science
Published (Last): 27 May 2014
Pages: 72
PDF File Size: 14.71 Mb
ePub File Size: 8.82 Mb
ISBN: 626-3-90410-344-6
Downloads: 31297
Price: Free* [*Free Regsitration Required]
Uploader: Mozil

Access to the text HTML. Personal information regarding our website’s visitors, including their identity, is confidential. As per the Law relating to information storage and personal integrity, you have mgeloide right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.

N Engl J Med. Chronic myeloid leukemia advances in biology and new approaches to treatment.

For the remaining half of patients, the causes leading to the molecular relapse deserve to be further analyzed. Access to the full text of this article requires a subscription. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties. Les inhibiteurs des kinases. Imatinib mesylate therapy in patients of chronic myeloid leukemia with Philadelphia chromosome positive: Contact Help Who are we?


The persistence of TKI-refractory leukemic stem cells could explain this result. You can move this window by clicking on the headline. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low myfloide middle income countries.

Clinical trials have validated TKI discontinuation strategies in patients with sustained deep molecular response. A retrospective study of leukemia epidemiology in Northern Tunisia.

An experience from eastern India. Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi. Journal page Archives Contents list. Clinical and pronognostic features of Nigerians with chronic myeloid leukemia. Outline Masquer le plan. Molecular biology of bcr-abl1-positive CML.

New technologies digital PCR, high-throughput sequencing or NGS were developed to improve the performances of existing methods. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction. Chronic myeloid leukaemia in central Africans. Access to the PDF text. Top of the page – Article Outline. S Af Med J.

New strategies to eradicate these residual cells by targeting the hematopoietic niche or directly the leukemic stem cells are being developed.

Indian J Hematol Blood Transfus.

Leucémie myéloïde chronique | Blausen Medical

If you want to subscribe to this journal, see our rates You can purchase this item in Pay Per View: Acellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Tyrosine kinase inhibitor TKI therapy imatinib, dasatinib, nilotinib, bosutinib, ponatinib has led to improved overall and cheonique survival of patients.


Finally, the immune system undoubtedly plays a crucial function in the control of residual leukemic cells; this role should be specified in the future. The Glivec international patient assistance programme: East Afr Med J. Analysis myeliide the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.

Leucémie myéloïde chronique

International recommendations facilitate the management of CML and treatment adjustments. Hematologic and cytogenetic response to Imatinib mesylate in chronic myelogenous leukemia. Chronic myeloid leukaemia in South African lekcemie.

You may thus request myelooide your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.